No Cover Image

Journal article 613 views 112 downloads

Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies

Iris Szu-Szu Ho Orcid Logo, Amaya Azcoaga-Lorenzo Orcid Logo, Ashley Akbari Orcid Logo, Jim Davies, Peter Hodgins, Kamlesh Khunti Orcid Logo, Umesh Kadam, Ronan Lyons Orcid Logo, Colin McCowan, Stewart W Mercer Orcid Logo, Krishnarajah Nirantharakumar, Bruce Guthrie Orcid Logo

BMJ Open, Volume: 12, Issue: 4, Start page: e057017

Swansea University Authors: Ashley Akbari Orcid Logo, Ronan Lyons Orcid Logo

  • 59936.VOR.pdf

    PDF | Version of Record

    Distributed under a creative commons attribution non commercial (CC-BY-NC 4.0) licence.

    Download (1.83MB)

Check full text

DOI (Published version): 10.1136/bmjopen-2021-057017

Abstract

Objective: (1) To estimate the pooled prevalence of multimorbidity in all age groups, globally. (2) To examine how measurement of multimorbidity impacted the estimated prevalence. Methods: In this systematic review and meta-analysis, we conducted searches in nine bibliographic databases (PsycINFO, E...

Full description

Published in: BMJ Open
ISSN: 2044-6055 2044-6055
Published: BMJ 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa59936
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2022-05-20T10:49:44Z
last_indexed 2022-05-28T03:35:19Z
id cronfa59936
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2022-05-27T10:14:45.4501157</datestamp><bib-version>v2</bib-version><id>59936</id><entry>2022-05-02</entry><title>Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies</title><swanseaauthors><author><sid>aa1b025ec0243f708bb5eb0a93d6fb52</sid><ORCID>0000-0003-0814-0801</ORCID><firstname>Ashley</firstname><surname>Akbari</surname><name>Ashley Akbari</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>83efcf2a9dfcf8b55586999d3d152ac6</sid><ORCID>0000-0001-5225-000X</ORCID><firstname>Ronan</firstname><surname>Lyons</surname><name>Ronan Lyons</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-05-02</date><deptcode>HDAT</deptcode><abstract>Objective: (1) To estimate the pooled prevalence of multimorbidity in all age groups, globally. (2) To examine how measurement of multimorbidity impacted the estimated prevalence. Methods: In this systematic review and meta-analysis, we conducted searches in nine bibliographic databases (PsycINFO, Embase, Global Health, Medline, Scopus, Web of Science, Cochrane Library, CINAHL and ProQuest Dissertations and Theses Global) for prevalence studies published between database inception and 21 January 2020. Studies reporting the prevalence of multimorbidity (in all age groups and in community, primary care, care home and hospital settings) were included. Studies with an index condition or those that did not include people with no long-term conditions in the denominator were excluded. Retrieved studies were independently reviewed by two reviewers, and relevant data were extracted using predesigned pro forma. We used meta-analysis to pool the estimated prevalence of multimorbidity across studies, and used random-effects meta-regression and subgroup analysis to examine the association of heterogeneous prevalence estimates with study and measure characteristics. Results: 13&#x2009;807 titles were screened, of which 193 met inclusion criteria for meta-analysis. The pooled prevalence of multimorbidity was 42.4% (95% CI 38.9% to 46.0%) with high heterogeneity (I2 &gt;99%). In adjusted meta-regression models, participant mean age and the number of conditions included in a measure accounted for 47.8% of heterogeneity in effect sizes. The estimated prevalence of multimorbidity was significantly higher in studies with older adults and those that included larger numbers of conditions. There was no significant difference in estimated prevalence between low-income or middle-income countries (36.8%) and high-income countries (44.3%), or between self-report (40.0%) and administrative/clinical databases (52.7%). Conclusions: The pooled prevalence of multimorbidity was significantly higher in older populations and when studies included a larger number of baseline conditions. The findings suggest that, to improve study comparability and quality of reporting, future studies should use a common core conditions set for multimorbidity measurement and report multimorbidity prevalence stratified by sociodemographics.</abstract><type>Journal Article</type><journal>BMJ Open</journal><volume>12</volume><journalNumber>4</journalNumber><paginationStart>e057017</paginationStart><paginationEnd/><publisher>BMJ</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>2044-6055</issnPrint><issnElectronic>2044-6055</issnElectronic><keywords>Systematic Review</keywords><publishedDay>29</publishedDay><publishedMonth>4</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-04-29</publishedDate><doi>10.1136/bmjopen-2021-057017</doi><url/><notes/><college>COLLEGE NANME</college><department>Health Data Science</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HDAT</DepartmentCode><institution>Swansea University</institution><apcterm>Another institution paid the OA fee</apcterm><funders>This study was funded by Health Data Research UK (CFC0110).</funders><lastEdited>2022-05-27T10:14:45.4501157</lastEdited><Created>2022-05-02T13:15:30.6040162</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Iris Szu-Szu</firstname><surname>Ho</surname><orcid>0000-0003-4980-7780</orcid><order>1</order></author><author><firstname>Amaya</firstname><surname>Azcoaga-Lorenzo</surname><orcid>0000-0003-3307-878x</orcid><order>2</order></author><author><firstname>Ashley</firstname><surname>Akbari</surname><orcid>0000-0003-0814-0801</orcid><order>3</order></author><author><firstname>Jim</firstname><surname>Davies</surname><order>4</order></author><author><firstname>Peter</firstname><surname>Hodgins</surname><order>5</order></author><author><firstname>Kamlesh</firstname><surname>Khunti</surname><orcid>0000-0003-2343-7099</orcid><order>6</order></author><author><firstname>Umesh</firstname><surname>Kadam</surname><order>7</order></author><author><firstname>Ronan</firstname><surname>Lyons</surname><orcid>0000-0001-5225-000X</orcid><order>8</order></author><author><firstname>Colin</firstname><surname>McCowan</surname><order>9</order></author><author><firstname>Stewart W</firstname><surname>Mercer</surname><orcid>0000-0002-1703-3664</orcid><order>10</order></author><author><firstname>Krishnarajah</firstname><surname>Nirantharakumar</surname><order>11</order></author><author><firstname>Bruce</firstname><surname>Guthrie</surname><orcid>0000-0003-4191-4880</orcid><order>12</order></author></authors><documents><document><filename>59936__24135__3c236881eafb4bc1894204810e81eb6a.pdf</filename><originalFilename>59936.VOR.pdf</originalFilename><uploaded>2022-05-20T11:47:16.3639231</uploaded><type>Output</type><contentLength>1919044</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Distributed under a creative commons attribution non commercial (CC-BY-NC 4.0) licence.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by-nc/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2022-05-27T10:14:45.4501157 v2 59936 2022-05-02 Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies aa1b025ec0243f708bb5eb0a93d6fb52 0000-0003-0814-0801 Ashley Akbari Ashley Akbari true false 83efcf2a9dfcf8b55586999d3d152ac6 0000-0001-5225-000X Ronan Lyons Ronan Lyons true false 2022-05-02 HDAT Objective: (1) To estimate the pooled prevalence of multimorbidity in all age groups, globally. (2) To examine how measurement of multimorbidity impacted the estimated prevalence. Methods: In this systematic review and meta-analysis, we conducted searches in nine bibliographic databases (PsycINFO, Embase, Global Health, Medline, Scopus, Web of Science, Cochrane Library, CINAHL and ProQuest Dissertations and Theses Global) for prevalence studies published between database inception and 21 January 2020. Studies reporting the prevalence of multimorbidity (in all age groups and in community, primary care, care home and hospital settings) were included. Studies with an index condition or those that did not include people with no long-term conditions in the denominator were excluded. Retrieved studies were independently reviewed by two reviewers, and relevant data were extracted using predesigned pro forma. We used meta-analysis to pool the estimated prevalence of multimorbidity across studies, and used random-effects meta-regression and subgroup analysis to examine the association of heterogeneous prevalence estimates with study and measure characteristics. Results: 13 807 titles were screened, of which 193 met inclusion criteria for meta-analysis. The pooled prevalence of multimorbidity was 42.4% (95% CI 38.9% to 46.0%) with high heterogeneity (I2 >99%). In adjusted meta-regression models, participant mean age and the number of conditions included in a measure accounted for 47.8% of heterogeneity in effect sizes. The estimated prevalence of multimorbidity was significantly higher in studies with older adults and those that included larger numbers of conditions. There was no significant difference in estimated prevalence between low-income or middle-income countries (36.8%) and high-income countries (44.3%), or between self-report (40.0%) and administrative/clinical databases (52.7%). Conclusions: The pooled prevalence of multimorbidity was significantly higher in older populations and when studies included a larger number of baseline conditions. The findings suggest that, to improve study comparability and quality of reporting, future studies should use a common core conditions set for multimorbidity measurement and report multimorbidity prevalence stratified by sociodemographics. Journal Article BMJ Open 12 4 e057017 BMJ 2044-6055 2044-6055 Systematic Review 29 4 2022 2022-04-29 10.1136/bmjopen-2021-057017 COLLEGE NANME Health Data Science COLLEGE CODE HDAT Swansea University Another institution paid the OA fee This study was funded by Health Data Research UK (CFC0110). 2022-05-27T10:14:45.4501157 2022-05-02T13:15:30.6040162 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Iris Szu-Szu Ho 0000-0003-4980-7780 1 Amaya Azcoaga-Lorenzo 0000-0003-3307-878x 2 Ashley Akbari 0000-0003-0814-0801 3 Jim Davies 4 Peter Hodgins 5 Kamlesh Khunti 0000-0003-2343-7099 6 Umesh Kadam 7 Ronan Lyons 0000-0001-5225-000X 8 Colin McCowan 9 Stewart W Mercer 0000-0002-1703-3664 10 Krishnarajah Nirantharakumar 11 Bruce Guthrie 0000-0003-4191-4880 12 59936__24135__3c236881eafb4bc1894204810e81eb6a.pdf 59936.VOR.pdf 2022-05-20T11:47:16.3639231 Output 1919044 application/pdf Version of Record true Distributed under a creative commons attribution non commercial (CC-BY-NC 4.0) licence. true eng http://creativecommons.org/licenses/by-nc/4.0/
title Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies
spellingShingle Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies
Ashley Akbari
Ronan Lyons
title_short Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies
title_full Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies
title_fullStr Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies
title_full_unstemmed Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies
title_sort Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies
author_id_str_mv aa1b025ec0243f708bb5eb0a93d6fb52
83efcf2a9dfcf8b55586999d3d152ac6
author_id_fullname_str_mv aa1b025ec0243f708bb5eb0a93d6fb52_***_Ashley Akbari
83efcf2a9dfcf8b55586999d3d152ac6_***_Ronan Lyons
author Ashley Akbari
Ronan Lyons
author2 Iris Szu-Szu Ho
Amaya Azcoaga-Lorenzo
Ashley Akbari
Jim Davies
Peter Hodgins
Kamlesh Khunti
Umesh Kadam
Ronan Lyons
Colin McCowan
Stewart W Mercer
Krishnarajah Nirantharakumar
Bruce Guthrie
format Journal article
container_title BMJ Open
container_volume 12
container_issue 4
container_start_page e057017
publishDate 2022
institution Swansea University
issn 2044-6055
2044-6055
doi_str_mv 10.1136/bmjopen-2021-057017
publisher BMJ
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
description Objective: (1) To estimate the pooled prevalence of multimorbidity in all age groups, globally. (2) To examine how measurement of multimorbidity impacted the estimated prevalence. Methods: In this systematic review and meta-analysis, we conducted searches in nine bibliographic databases (PsycINFO, Embase, Global Health, Medline, Scopus, Web of Science, Cochrane Library, CINAHL and ProQuest Dissertations and Theses Global) for prevalence studies published between database inception and 21 January 2020. Studies reporting the prevalence of multimorbidity (in all age groups and in community, primary care, care home and hospital settings) were included. Studies with an index condition or those that did not include people with no long-term conditions in the denominator were excluded. Retrieved studies were independently reviewed by two reviewers, and relevant data were extracted using predesigned pro forma. We used meta-analysis to pool the estimated prevalence of multimorbidity across studies, and used random-effects meta-regression and subgroup analysis to examine the association of heterogeneous prevalence estimates with study and measure characteristics. Results: 13 807 titles were screened, of which 193 met inclusion criteria for meta-analysis. The pooled prevalence of multimorbidity was 42.4% (95% CI 38.9% to 46.0%) with high heterogeneity (I2 >99%). In adjusted meta-regression models, participant mean age and the number of conditions included in a measure accounted for 47.8% of heterogeneity in effect sizes. The estimated prevalence of multimorbidity was significantly higher in studies with older adults and those that included larger numbers of conditions. There was no significant difference in estimated prevalence between low-income or middle-income countries (36.8%) and high-income countries (44.3%), or between self-report (40.0%) and administrative/clinical databases (52.7%). Conclusions: The pooled prevalence of multimorbidity was significantly higher in older populations and when studies included a larger number of baseline conditions. The findings suggest that, to improve study comparability and quality of reporting, future studies should use a common core conditions set for multimorbidity measurement and report multimorbidity prevalence stratified by sociodemographics.
published_date 2022-04-29T04:17:37Z
_version_ 1763754175370362880
score 11.037603

Similar Items